Luca Van Der Kraan, a clinical laboratory scientist at Rady Children’s Institute for Genomic Medicine, prepares to wash a sequencing machine. Rady has embraced genomics to help diagnose critically ill newborns. File photo by Jamie Scott Lytle

Luca Van Der Kraan, a clinical laboratory scientist at Rady Children’s Institute for Genomic Medicine, prepares to wash a sequencing machine. Rady has embraced genomics to help diagnose critically ill newborns. File photo by Jamie Scott Lytle

A division of Rady Children’s Hospital that deploys quick-turnaround genomic sequencing in puzzling cases has added six board members.

The new board members of the Rady Children’s Institute for Genomic Medicine:

· Joe Beery, senior vice president and chief information officer of Thermo Fisher Scientific;

· Scott Kahn, chief information officer of Luna PBC;

· Donald Kearns, president emeritus of Rady Children’s Hospital and Health Center;

· Frederic Luddy, founder and board chairman of ServiceNow;

· Trindl Reeves, principal at Marsh & McLennan Insurance Agency; and

· Jon Soderstrom, managing director, office of cooperative research at Yale University

The additions bring the board, chaired by biotech fixture David Hale, to 18 members. A board term is three years.

In January, the San Diego Business Journal covered San Diego’s leading role in a push for wider insurance coverage of genomics, including Rady Children’s Institute for Genomic Medicine.

In a first-of-its-kind pilot, the state program Medi-Cal last year began covering rapid sequencing of critically ill newborns at Rady. The pilot could convince Medi-Cal — and private insurers — to cover high-speed sequencing to help diagnose critically-ill newborns.